Cargando…

CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Corrections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392422/ https://www.ncbi.nlm.nih.gov/pubmed/25805050 http://dx.doi.org/10.1161/JAHA.115.000750

Ejemplares similares

CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response
por: Kasahara, Kazuyuki, et al.
Publicado: (2014)

Correction: Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Publicado: (2023)

Depletion of Foxp3(+) regulatory T cells augments CD4(+) T cell immune responses in atherosclerosis-prone hypercholesterolemic mice
por: Kasahara, Kazuyuki, et al.
Publicado: (2022)

Correction: Curcumin Inhibits CD4(+) T Cell Activation, but Augments CD69 Expression and TGF-β1-Mediated Generation of Regulatory T Cells at Late Phase
por: Kim, Girak, et al.
Publicado: (2013)

IL-33 reduces the development of atherosclerosis
por: Miller, Ashley M., et al.
Publicado: (2012)

Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity
por: Wang, Chun Jing, et al.
Publicado: (2023)

Correction: Depletion of CD4(+) CD25(+) Regulatory T Cells Promotes CCL21-Mediated Antitumor Immunity
Publicado: (2014)

Correction: Characterization of Protective Human CD4(+)CD25(+) FOXP3(+) Regulatory T Cells Generated with IL-2, TGF-β and Retinoic Acid
por: Lu, Ling, et al.
Publicado: (2011)

CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells
por: Dawicki, Wojciech, et al.
Publicado: (2021)

Correction: Ultrasound combined with nanobubbles promotes systemic anticancer immunity and augments anti-PD1 efficacy
Publicado: (2022)

Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis
por: Trinschek, Bettina, et al.
Publicado: (2013)

Correction: Combined Chromatin and Expression Analysis Reveals Specific Regulatory Mechanisms within Cytokine Genes in the Macrophage Early Immune Response
por: Jesus Iglesias, Maria, et al.
Publicado: (2012)

Correction: Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2017)

Correction to: Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma
por: Hadi, Marym Mohammad, et al.
Publicado: (2023)

CD47-Blocking Antibodies and Atherosclerosis
por: Ryan, John J.
Publicado: (2016)

Correction: On the mechanism of anti-CD39 immune checkpoint therapy
Publicado: (2020)

Correction: Estradiol Enhances CD4(+) T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce T(h)17 Responses via an IL-1-Dependent Pathway
por: Anipindi, Varun C., et al.
Publicado: (2016)

Correction: A Human Trypanosome Suppresses CD8(+) T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4(+) Foxp3(+) T Cells
por: Ersching, Jonatan, et al.
Publicado: (2016)

Cholera toxin inhibits IL-12 production and CD8α(+) dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function
por: la Sala, Andrea, et al.
Publicado: (2009)

Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
por: Tallantyre, E. C., et al.
Publicado: (2018)

Anti-4-1BB antibody-based combination therapy augments antitumor immunity by enhancing CD11c(+)CD8(+) T cells in renal cell carcinoma
por: Ju, Seong-A, et al.
Publicado: (2022)

Correction: Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Publicado: (2021)

Correction: SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4(+) T Cells into CD4(+)FoxP3(+) T Regulatory Cells by Production of IFN-γ
por: Madireddi, Shravan, et al.
Publicado: (2012)

Correction: In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis
Publicado: (2021)

MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity
por: Yarchoan, Mark, et al.
Publicado: (2019)

Correction for: Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells
por: Huang, Shushi, et al.
Publicado: (2022)

Correction: A new oncolytic Vaccinia virus augments antitumor immune responses to prevent tumor recurrence and metastasis after surgery
Publicado: (2020)

Correction: IL-17A weakens the antitumor immunity by inhibiting apoptosis of MDSCs in Lewis lung carcinoma bearing mice
por: Wang, Juan, et al.
Publicado: (2022)

Correction: IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy
Publicado: (2021)

Correction: GagPol-specific CD4(+) T-cells increase the antibody response to Env by intrastructural help
por: Nabi, Ghulam, et al.
Publicado: (2013)

IMiDs Augment CD3-Bispecific Antibody–Induced CD8(+) T-Cell Cytotoxicity and Expansion by Enhancing IL2 Production
por: Li, Ji, et al.
Publicado: (2023)

Correction: Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34(+) Stem Cells-Reconstituted NOD-scid IL2rγ(null) Mice
Publicado: (2014)

Correction: Combinatorial Signaling through TLR-2 and CD86 Augments Activation and Differentiation of Resting B Cells
por: Jain, Shweta, et al.
Publicado: (2014)

Correction: Survival, CD4 T lymphocyte count recovery and immune reconstitution pattern during the first-line combination antiretroviral therapy in patients with HIV-1 infection in Mongolia
por: Bayarsaikhan, Solongo, et al.
Publicado: (2022)

CD4(+) regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
por: Friedline, Randall H., et al.
Publicado: (2009)

Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
por: Ait-Oufella, Hafid, et al.
Publicado: (2021)

Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
por: Kumar, Amrendra, et al.
Publicado: (2023)

c-Rel is required for the development of thymic Foxp3(+) CD4 regulatory T cells
por: Isomura, Iwao, et al.
Publicado: (2010)

Correction: CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets
por: Smigiel, Kate S., et al.
Publicado: (2019)

IL-15 Augments TCR-Induced CD4(+) T Cell Expansion In Vitro by Inhibiting the Suppressive Function of CD25(High) CD4(+) T Cells
por: Van Belle, Tom L., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qvidt6lnqbscnj8g15kfnev9a9